Eucrates Biomedical Acquisition Corp. (EUCR)
NASDAQ: EUCR · IEX Real-Time Price · USD
10.02
0.00 (0.00%)
Jan 26, 2023, 4:00 PM EST - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 |
|---|---|---|
| Selling, General & Admin
|
0.74 | 0.15 |
| Operating Expenses
|
0.74 | 0.15 |
| Operating Income
|
-0.74 | -0.15 |
| Other Expense / Income
|
-4.57 | 4.77 |
| Pretax Income
|
3.82 | -4.92 |
| Net Income
|
3.82 | -4.92 |
| Shares Outstanding (Basic)
|
13 | 8 |
| Shares Outstanding (Diluted)
|
13 | 8 |
| Shares Change
|
69.68% | - |
| EPS (Basic)
|
0.28 | -0.62 |
| EPS (Diluted)
|
0.28 | -0.62 |
| Free Cash Flow Per Share
|
-0.04 | -0.07 |
| EBITDA
|
3.82 | -4.92 |
| EBIT
|
3.82 | -4.92 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).